相关实验视频
Updated: Jan 17, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
在特殊条件下管理糖尿病酸性脂肪酸症:困难和困境
1Department of Endocrinology, All India Institute of Medical Sciences, Bhubaneswar 751019, India.
World journal of diabetes
|September 22, 2025
概括
在高风险患者中管理糖尿病酸性 (DKA) 需要仔细考虑个体因素. 这项研究解决了挑战,并为复杂的DKA病例提供了方法,包括那些具有并发症的病例.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 儿科 儿科 儿科
背景情况:
- 糖尿病酸症 (DKA) 的住院率正在增加,这给管理带来了挑战,特别是在高风险人群中.
- 患者特定的因素,如怀孕,病,心脏病,晚年和SGLT2抑制剂使用,使DKA治疗复杂化.
- 由于潜在的长期神经系统后果,儿科DKA需要专门的护理.
研究的目的:
- 为了解决患有特定疾病和并发症的患者糖尿病酸性脂肪酸症管理的复杂性.
- 为高风险的DKA病例提供量身定制的管理策略,目前的指导方针往往缺乏.
- 为了澄清争议,并指导复杂的DKA场景的最佳治疗方法.
主要方法:
- 关于糖尿病酸性脂肪酸症管理的最新研究和临床指导方针的审查.
- 对影响DKA治疗方案的患者因素和并发症的分析.
- 综合证据,提出复杂DKA患者管理的方法.
主要成果:
- 确定影响DKA管理的关键因素 (怀孕,/心脏病,年龄,SGLT2抑制剂).
- 承认需要专门的儿科DKA护理及其神经学影响.
- 突出了当前管理复杂DKA案件的指导方针中的差距.
结论:
- 针对性管理策略对于具有伴随性疾病的高风险糖尿病酸症患者至关重要.
- 需要进一步的研究来解决争议并优化DKA治疗方案.
- 这项工作旨在为管理复杂的糖尿病酸性症表现提供框架.
相关概念视频
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Hypoglycemia and Glucagon
838
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
838
Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K

